1 Laboratory of Cancer Genetics and Cytogenetics, Memorial Sloan-Kettering Cancer Center, New York
Fanconi anemia (FA) is characterized by pancytopenia, spontaneous chromosome instability, and a variety of congenital anomalies. Variable phenotype and age of onset of anemia make accurate diagnosis difficult in some patients. We report a cytogenetic method for rapid diagnosis of FA homozygous blood lymphocytes and amniotic fluid cells, and FA heterozygous blood lymphocytes. When treated with 0.1 µg/ml of diepoxybutane, affected lymphocytes responded with approximately a 175-fold increase in chromosome breakage compared with that exhibited by similarly treated lymphocytes from normal individuals or patients who manifest some clinical features of FA. The breakage in affected lymphocytes was characterized by multiple complex chromatid exchanges. Amniotic fluid cells from four fetuses at risk for FA were studied. Three of these were diagnosed as affected and the fourth as normal on the basis of spontaneous and diepoxybutane-induced chromosome breakage. Lymphocytes from FA heterozygotes showed a fourfold increase in chromosome breakage characterized by chromatid exchange when compared with control lymphocytes. Prenatal and postnatal diagnosis of FA and detection of carriers can therefore be performed with ease by making use of the method described here.
Submitted on April 21, 1980
This article has been cited by other articles:
![]() |
M. W. Lensch, M. Tischkowitz, T. A. Christianson, C. A. Reifsteck, S. A. Speckhart, P. M. Jakobs, M. E. O'Dwyer, S. B. Olson, M. M. Le Beau, S. V. Hodgson, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia Blood, July 1, 2003; 102(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Fagerlie, J. Diaz, T. A. Christianson, K. McCartan, W. Keeble, G. R. Faulkner, and G. C. Bagby Functional correction of FA-C cells with FANCC suppresses the expression of interferon {gamma}-inducible genes Blood, May 15, 2001; 97(10): 3017 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al. Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry Pediatrics, April 1, 2001; 107(4): 744 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Rathbun, T. A. Christianson, G. R. Faulkner, G. Jones, W. Keeble, M. O'Dwyer, and G. C. Bagby Interferon-gamma -induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members Blood, December 15, 2000; 96(13): 4204 - 4211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Brois, L. W. McMahon, N. I. Ramos, L. M. Anglin, C. E. Walsh, and M. W. Lambert A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA Carcinogenesis, September 1, 1999; 20(9): 1845 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Solder, M. Weiss, A. Jager, and B. H. Belohradsky Dyskeratosis Congenita: Multisystemic Disorder with Special Consideration of Immunologic Aspects: A Review of the Literature Clinical Pediatrics, September 1, 1998; 37(9): 521 - 530. [Abstract] [PDF] |
||||
![]() |
M. E. Hoatlin, T. A. Christianson, W. W. Keeble, A. T. Hammond, Y. Zhi, M. C. Heinrich, P. A. Tower, and G. C. Bagby Jr The Fanconi Anemia Group C Gene Product Is Located in Both the Nucleus and Cytoplasm of Human Cells Blood, February 15, 1998; 91(4): 1418 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Rathbun, G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al. Inactivation of the Fanconi Anemia Group C Gene Augments Interferon-gamma -Induced Apoptotic Responses in Hematopoietic Cells Blood, August 1, 1997; 90(3): 974 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Shannon, M. J. Cowan, and K. K. Matthay Pediatric Bone Marrow Transplantation: Intensive Care Management J Intensive Care Med, November 1, 1987; 2(6): 328 - 344. [Abstract] [PDF] |
||||